Comprehensive Analysis and Experimental Validation of FOXD2 as a Novel Potential Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma
- 1 September 2025
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Computer-Aided Drug Design
- Vol. 21 (6) , 860-871
Abstract
Background: The role of Forkhead Box D2 (FOXD2) in head and neck squamous cell carcinoma (HNSC) has never been studied. Objectives: Our object was to explore the role of FOXD2 in HNSC. Methods: Clinical data for patients with HNSC was obtained from TCGA. Our study examined the atypical expression of FOXD2 in both HNSC and pan-cancer, along with its diagnostic and prognostic implications, as well as the association between FOXD2 expression and clinical characteristics, immune infiltration, immune checkpoint genes, and MSI. Gene set enrichment analysis (GESA) was used to investigate the potential regulation network of FOXD2 in HNSC. We analyze the genomic alterations of FOXD2 in HNSC. GSE13397 and qRT-PCR were used for the validation of FOXD2 expression. Results: FOXD2 was aberrantly expressed in 24 tumors. FOXD2 was significantly up-regulated in HNSC compared to normal head and neck tissue (p < 0.001). High FOXD2 expression was associated with the histologic grade of the patient with HNSC (p < 0.001), lymphovascular infiltration (p = 0.002) and lymph node neck dissection (p = 0.002). In HNSC, an autonomous correlation between FOXD2 expression and OS was observed (HR: 1.36; 95% CI: 1.04-1.78; p = 0.026). FOXD2 was associated with the neuronal system, neuroactive ligand-receptor interaction, and retinoblastoma gene in cancer. FOXD2 was associated with immune infiltration, immune checkpoints, and MSI. The somatic mutation rate of FOXD2 in HNSC was 0.2%. FOXD2 was significantly up-regulated in HNSC cell lines. Conclusion: Our findings suggest that FOXD2 has the potential to serve as a prognostic biomarker and immunotherapeutic target for individuals with HNSC.Keywords
This publication has 36 references indexed in Scilit:
- FOXD2 regulations IQGAP3 mediated Ca2+ signaling pathway to facilitate gastric adenocarcinoma cell promotionThe Kaohsiung Journal of Medical Sciences, 2023
- High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR‐10b‐5p/EIF5A2 regulatory axis in head and neck squamous cell carcinomaJournal of Clinical Laboratory Analysis, 2022
- Identity of MMP1 and its effects on tumor progression in head and neck squamous cell carcinomaCancer Medicine, 2022
- Head and neck cancer: Current challenges and future perspectives2021
- Immunotherapy for Head and Neck CancerOral and Maxillofacial Surgery Clinics of North America, 2019
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human CancerImmunity, 2013
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Forkhead transcription factors in immunologyCellular and Molecular Life Sciences, 2005
- Temporal and spatial expression patterns of FoxD2 during the early development of Xenopus laevisMechanisms of Development, 2002
- Cloning and Characterization offreac-9 (FKHL171),a Novel Kidney-Expressed Human Forkhead Gene That Maps to Chromosome 1p32–p34Genomics, 1997